医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
JNJ · JOHNSON & JOHNSON
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
JOHNSON & JOHNSON（JNJ）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $67.8M；高管董事有效买入 —、有效卖出 $12.5M。最近申报 2026-09-04。
买入 Bought—
卖出 Sold$67.8M
有效买入 Effective bought—
有效卖出 Effective sold$12.5M
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-02 | Schmid Timothy EVP, WW Chair, MedTech | 卖出 Sell | 33,597 | $274.74 | $9.2M | SEC |
| 2026-08-17 | Taubert Jennifer L EVP, WWC. Innovative Medicine | 卖出 Sell | 15,000 | $263.36 | $4.0M | SEC |
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board, Director | 卖出 Sell | 123,291 | $261.17 | $32.2M | SEC |
| 2026-08-05 | Duato Joaquin CEO and Chairman of the Board, Director | 卖出 Sell · 有效 | 48,480 | $258.15 | $12.5M | SEC |
| 2026-08-06 | Forminard Elizabeth EVP, Chief Legal Officer | 卖出 Sell | 15,918 | $257.00 | $4.1M | SEC |
| 2026-07-20 | Broadhurst Vanessa EVP, Global Corp Affairs | 卖出 Sell | 23,054 | $251.27 | $5.8M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-02 | Schmid Timothy Officer | 33,597 | $9.2M | |
| 2026-08-17 | Taubert Jennifer L Officer | 15,000 | $4.0M | |
| 2026-08-13 | Duato Joaquin Officer, Director | 123,291 | $32.2M | |
| 2026-08-06 | Forminard Elizabeth Officer | 15,918 | $4.1M | |
| 2026-08-05 | Duato Joaquin CEO, Chariman | 48,480 | $12.4M | |
| 2026-07-20 | Broadhurst Vanessa Officer | 23,054 | $5.8M |
内部人 Insiders
Schmid Timothy、Taubert Jennifer L、Duato Joaquin、Forminard Elizabeth、Broadhurst Vanessa